Digest Network Come funziona
Network
/
Società
OK
Non verificato

OKYO Pharma LTD

Di cosa scriviamo

Annunci EconomiciBiotecnologiaFinanzaFondi di investimentoMedicina Salute Benessere

33 comunicati stampa

Guarda tutti i comunicati
12/11/2026
Biotecnologia
OKYO Pharma to Participate in 2026 Jefferies Global Healthcare Conference in London
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
05/11/2026
Biotecnologia
Medicina Salute Benessere
OKYO Pharma to Present at the Stifel 2026 Healthcare Conference
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
06/10/2026
Biotecnologia
Medicina Salute Benessere
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
29/09/2026
Biotecnologia
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
09/09/2026
Biotecnologia
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
08/09/2026
Biotecnologia
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
28/07/2026
Biotecnologia
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
27/07/2026
Biotecnologia
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
23/07/2026
Biotecnologia
Finanza
OKYO Pharma Announces Purchase of Shares by Director
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
23/07/2026
Biotecnologia
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0